AmacaThera is a clinical-stage company transforming therapeutics to make a difference in patient health. AmacaGel™, a unique, injectable hydrogel platform, provides localized sustained drug delivery to improve patient outcomes across multiple therapeutic areas, including post-surgical pain management, cancer, and other hard-to-reach unmet medical needs. AMT-143 is the lead program for post-operative pain and is currently in Phase 1 trials.

AmacaThera logo



Event details

Date: June 5 - 8, 2023

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


33 in total